Incentive drugs for substitute dispensing decline in January

A total of 3,777 incentive drugs (including 155 control drugs), which have been endorsed by bioequivalence tests, are available for substitute dispensing as of January 31 this year, down 146 items compared with 3,923 items last October, according to data released by the Health Insurance Review and Assessment Service (HIRA).

The decrease in the number of incentive drugs has been chiefly attri...